You Will Know That Despite Being HIV Positive You Are Not Alone: Qualitative Study to Inform Content of a Text Messaging Intervention to Improve Prevention of Mother-to-Child HIV Transmission

Jade Fairbanks, Kristin Beima-Sofie, Pamela Akinyi, Daniel Matemo, Jennifer A Unger, John Kinuthia, Gabrielle O'Malley, Alison L Drake, Grace John-Stewart, Keshet Ronen, Jade Fairbanks, Kristin Beima-Sofie, Pamela Akinyi, Daniel Matemo, Jennifer A Unger, John Kinuthia, Gabrielle O'Malley, Alison L Drake, Grace John-Stewart, Keshet Ronen

Abstract

Background: Prevention of mother-to-child HIV transmission (PMTCT) relies on long-term adherence to antiretroviral therapy (ART). Mobile health approaches, such as text messaging (short message service, SMS), may improve adherence in some clinical contexts, but it is unclear what SMS content is desired to improve PMTCT-ART adherence.

Objective: We aimed to explore the SMS content preferences related to engagement in PMTCT care among women, male partners, and health care workers. The message content was used to inform an ongoing randomized trial to enhance the PMTCT-ART adherence.

Methods: We conducted 10 focus group discussions with 87 HIV-infected pregnant or postpartum women and semistructured individual interviews with 15 male partners of HIV-infected women and 30 health care workers from HIV and maternal child health clinics in Kenya. All interviews were recorded, translated, and transcribed. We analyzed transcripts using deductive and inductive approaches to characterize women's, partners', and health care workers' perceptions of text message content.

Results: All women and male partners, and most health care workers viewed text messages as a useful strategy to improve engagement in PMTCT care. Women desired messages spanning 3 distinct content domains: (1) educational messages on PMTCT and maternal child health, (2) reminder messages regarding clinic visits and adherence, and (3) encouraging messages that provide emotional support. While all groups valued reminder and educational messages, women highlighted emotional support more than the other groups (partners or health care workers). In addition, women felt that encouraging messages would assist with acceptance of their HIV status, support disclosure, improve patient-provider relationship, and provide support for HIV-related challenges. All 3 groups valued not only messages to support PMTCT or HIV care but also messages that addressed general maternal child health topics, stressing that both HIV- and maternal child health-related messages should be part of an SMS system for PMTCT.

Conclusions: Women, male partners, and health care workers endorsed SMS text messaging as a strategy to improve PMTCT and maternal child health outcomes. Our results highlight the specific ways in which text messaging can encourage and support HIV-infected women in PMTCT to remain in care, adhere to treatment, and care for themselves and their children.

Trial registration: ClinicalTrials.gov NCT02400671; https://ichgcp.net/clinical-trials-registry/NCT02400671 (Archived by WebCite at http://www.webcitation.org/70W7SVIVJ).

Keywords: ART; HIV; PMTCT; SMS text messaging; adherence; retention.

Conflict of interest statement

Conflicts of Interest: None declared.

©Jade Fairbanks, Kristin Beima-Sofie, Pamela Akinyi, Daniel Matemo, Jennifer A Unger, John Kinuthia, Gabrielle O'Malley, Alison L Drake, Grace John-Stewart, Keshet Ronen. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 19.07.2018.

Figures

Figure 1
Figure 1
Summary of themes discussed in focus group discussions and interviews. PMTCT: prevention of mother-to-child HIV transmission. SMS: short message service.

References

    1. UNAIDS UNAIDS Data 2017. 2017. [2018-06-14]. .
    1. Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, Spoerri A, Chimbwandira F, van OJJ, Keiser O. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study. Lancet HIV. 2016 Apr;3(4):e175–e182. doi: 10.1016/S2352-3018(16)00008-4.
    1. Tenthani L, Haas AD, Tweya H, Jahn A, van OJJ, Chimbwandira F, Chirwa Z, Ng'ambi W, Bakali A, Phiri S, Myer L, Valeri F, Zwahlen M, Wandeler G, Keiser O. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi. AIDS. 2014 Feb 20;28(4):589–598. doi: 10.1097/QAD.0000000000000143.
    1. Erlwanger AS, Joseph J, Gotora T, Muzunze B, Orne-Gliemann J, Mukungunugwa S, Farley T, Mangwiro A. Patterns of HIV care clinic attendance and adherence to antiretroviral therapy among pregnant and breastfeeding women living with HIV in the context of Option B+ in Zimbabwe. J Acquir Immune Defic Syndr. 2017 Dec 01;75 Suppl 2:S198–S206. doi: 10.1097/QAI.0000000000001347.
    1. Clouse K, Schwartz S, Van RA, Bassett J, Yende N, Pettifor A. “What they wanted was to give birth; nothing else”: barriers to retention in option B+ HIV care among postpartum women in South Africa. J Acquir Immune Defic Syndr. 2014 Sep 01;67(1):e12–e18. doi: 10.1097/QAI.0000000000000263.
    1. Ngarina M, Popenoe R, Kilewo C, Biberfeld G, Ekstrom AM. Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania. BMC Public Health. 2013 May 07;13:450. doi: 10.1186/1471-2458-13-450.
    1. Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, Mills EJ, Ho Y, Stringer JSA, McIntyre JA, Mofenson LM. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012 Oct 23;26(16):2039–2052. doi: 10.1097/QAD.0b013e328359590f.
    1. Thakkar J, Kurup R, Laba T, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile telephone text messaging for medication adherence in chronic disease: A meta-analysis. JAMA Intern Med. 2016 Mar;176(3):340–349. doi: 10.1001/jamainternmed.2015.7667.
    1. Mayer JE, Fontelo P. Meta-analysis on the effect of text message reminders for HIV-related compliance. AIDS Care. 2017 Apr;29(4):409–417. doi: 10.1080/09540121.2016.1214674.
    1. Kanters S, Park JJH, Chan K, Socias ME, Ford N, Forrest JI, Thorlund K, Nachega JB, Mills EJ. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV. 2017 Jan;4(1):e31–e40. doi: 10.1016/S2352-3018(16)30206-5.
    1. World Health Organization . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2nd edition. Recommendations for a Public Health Approach. Geneva: 2016. Jun, [2018-06-14].
    1. Jennings L, Ong'ech J, Simiyu R, Sirengo M, Kassaye S. Exploring the use of mobile phone technology for the enhancement of the prevention of mother-to-child transmission of HIV program in Nyanza, Kenya: a qualitative study. BMC Public Health. 2013;13:1131. doi: 10.1186/1471-2458-13-1131.
    1. Odeny TA, Newman M, Bukusi EA, McClelland RS, Cohen CR, Camlin CS. Developing content for a mHealth intervention to promote postpartum retention in prevention of mother-to-child HIV transmission programs and early infant diagnosis of HIV: a qualitative study. PLoS One. 2014;9(9):e106383. doi: 10.1371/journal.pone.0106383.
    1. Nachega JB, Skinner D, Jennings L, Magidson JF, Altice FL, Burke JG, Lester RT, Uthman OA, Knowlton AR, Cotton MF, Anderson JR, Theron GB. Acceptability and feasibility of mHealth and community-based directly observed antiretroviral therapy to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study. Patient Prefer Adherence. 2016;10:683–690. doi: 10.2147/PPA.S100002. doi: 10.2147/PPA.S100002.
    1. Musoke P, Gakumo CA, Abuogi LL, Akama E, Bukusi E, Helova A, Nalwa WZ, Onono M, Spangler SA, Wanga I, Turan JM. A text messaging intervention to support Option B+ in Kenya: A qualitative study. J Assoc Nurses AIDS Care. 2018;29(2):287–299. doi: 10.1016/j.jana.2017.09.009.
    1. Cataldo F, Chiwaula L, Nkhata M, van Lettow M, Kasende F, Rosenberg NE, Tweya H, Sampathkumar V, Hosseinipour M, Schouten E, Kapito-Tembo A, Eliya M, Chimbwandira F, Phiri S, PURE Malawi Consortium Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi. J Acquir Immune Defic Syndr. 2017 Dec 15;74(5):517–522. doi: 10.1097/QAI.0000000000001273.
    1. Woldesenbet SA, Jackson DJ, Lombard CJ, Dinh T, Ramokolo V, Doherty T, Sherman GG, Pillay Y, Goga AE. Structural level differences in the mother-to-child HIV transmission rate in South Africa: A multilevel assessment of individual-, health facility-, and provincial-level predictors of infant HIV transmission. J Acquir Immune Defic Syndr. 2017 Dec 15;74(5):523–530. doi: 10.1097/QAI.0000000000001289.
    1. Takah NF, Kennedy ITR, Johnman C. The impact of approaches in improving male partner involvement in the prevention of mother-to-child transmission of HIV on the uptake of maternal antiretroviral therapy among HIV-seropositive pregnant women in sub-Saharan Africa: a systematic review and meta-analysis. BMJ Open. 2017 Nov 25;7(11):e018207. doi: 10.1136/bmjopen-2017-018207.
    1. Aluisio AR, Bosire R, Bourke B, Gatuguta A, Kiarie JN, Nduati R, John-Stewart G, Farquhar C. Male partner participation in antenatal clinic services is associated with improved HIV-free survival among infants in Nairobi, Kenya: A prospective cohort study. J Acquir Immune Defic Syndr. 2016 Dec 01;73(2):169–176. doi: 10.1097/QAI.0000000000001038.
    1. Drake AL, Unger JA, Ronen K, Matemo D, Perrier T, DeRenzi B, Richardson BA, Kinuthia J, John-Stewart G. Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial. Contemp Clin Trials. 2017 Dec;57:44–50. doi: 10.1016/j.cct.2017.03.007.
    1. Ronen K, Unger JA, Drake AL, Perrier T, Akinyi P, Osborn L, Matemo D, O'Malley G, Kinuthia J, John-Stewart G. SMS messaging to improve ART adherence: perspectives of pregnant HIV-infected women in Kenya on HIV-related message content. AIDS Care. 2018 Apr;30(4):500–505. doi: 10.1080/09540121.2017.1417971.
    1. Kiarie JN, Kreiss JK, Richardson BA, John-Stewart GC. Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya. AIDS. 2003 Jan 03;17(1):65–71. doi: 10.1097/01.aids.0000042938.55529.e1.
    1. Mbuagbaw L, Bonono-Momnougui RC, Thabane L. Considerations in using text messages to improve adherence to highly active antiretroviral therapy: a qualitative study among clients in Yaoundé, Cameroon. HIV AIDS (Auckl) 2012 Apr;4:45–50. doi: 10.2147/HIV.S29954. doi: 10.2147/HIV.S29954.
    1. Rana Y, Haberer J, Huang H, Kambugu A, Mukasa B, Thirumurthy H, Wabukala P, Wagner GJ, Linnemayr S. Short message service (SMS)-based intervention to improve treatment adherence among HIV-positive youth in Uganda: focus group findings. PLoS One. 2015;10(4):e0125187. doi: 10.1371/journal.pone.0125187.
    1. Ware NC, Pisarski EE, Tam M, Wyatt MA, Atukunda E, Musiimenta A, Bangsberg DR, Haberer JE. The meanings in the messages: How SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 May 15;30(8):1287–1294. doi: 10.1097/QAD.0000000000001035.
    1. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010 Nov 27;376(9755):1838–1845. doi: 10.1016/S0140-6736(10)61997-6.
    1. van der Kop ML, Karanja S, Thabane L, Marra C, Chung MH, Gelmon L, Kimani J, Lester RT. In-depth analysis of patient-clinician cell phone communication during the WelTel Kenya1 antiretroviral adherence trial. PLoS One. 2012;7(9):e46033. doi: 10.1371/journal.pone.0046033.
    1. Lester RT. Ask, don't tell-mobile phones to improve HIV care. N Engl J Med. 2013 Nov 07;369(19):1867–1868. doi: 10.1056/NEJMc1311318.
    1. Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, Vreeman RC, Wilson I, Sam-Agudu NA, Blaschke TF, Vrijens B, Mellins CA, Remien RH, Weiser SD, Lowenthal E, Stirratt MJ, Sow PS, Thomas B, Ford N, Mills E, Lester R, Nachega JB, Bwana BM, Ssewamala F, Mbuagbaw L, Munderi P, Geng E, Bangsberg DR. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017;20(1):21371. doi: 10.7448/IAS.20.1.21371.
    1. Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014 Sep;11(3):291–307. doi: 10.1007/s11904-014-0220-1.
    1. Kaufman MR, Cornish F, Zimmerman RS, Johnson BT. Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. J Acquir Immune Defic Syndr. 2014 Aug 15;66 Suppl 3:S250–s258. doi: 10.1097/QAI.0000000000000236.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する